Aker BioMarine ASA: Minutes of Annual General Meeting

28 April 2026: The 2026 Annual General Meeting of Aker BioMarine ASA was held today as a digital meeting with online participation.

All resolutions were made in accordance with the proposals set out in the meeting notice.

The minutes of the meeting are attached and available at www.akerbiomarine.com/agm.

The general meeting re-elected Ola Snøve as Chair of the Board, re-elected Cilia Holmes Indahl and Frank O. Reite as members of the Board, and re-elected Kjell Inge Røkke as deputy member of the Board. Kathryn M. Baker was elected as a new member of the Board in replacement of Anne Harris and Kimberly Mathisen, thereby reducing the number of shareholder-elected board members from five to four. All were elected for a term of one year, until the Company's annual general meeting in 2027. The Board of Aker BioMarine ASA now consists of:

- Ola Snøve, Chair of the Board - Cilia Holmes Indahl - Frank O. Reite - Kathryn M. Baker - Kjell Inge Røkke (Deputy Member)

For further information, please contact

Lars Jacobsen, General Counsel Mobile: +47 906 05 306 Email: lars.jacobsen@akerbiomarine.com

About Aker BioMarine

Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.